Novartis Venture Fund Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
12
- Investments
-
361
- Portfolio
-
44
- Exits
-
183
Novartis Venture Fund General Information
Company Description
Founded in 1996, Novartis Venture Fund is a corporate venture capital arm of Novartis based in Basel, Switzerland. The firm prefers to invest in the life sciences, oncology, biotechnology, and digital health sectors.
Business Details
Website
www.nvfund.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- Postfach
- 4002 Basel
- Switzerland
Novartis Venture Fund Investments (361)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Seawolf Therapeutics | 16-Nov-2026 | Later Stage VC | Drug Discovery | Startup | ||
| Anaheim Bio | 01-Oct-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Kynexis | 19-Aug-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| RheumaLogics | 06-Aug-2026 | Other Commercial Products | Stealth | |||
| Fore Biotherapeutics | 08-Jul-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Sidewinder Therapeutics | 25-Mar-2026 | Drug Discovery | Generating Revenue | |||
| Averna Therapeutics | 19-Mar-2026 | Pharmaceuticals | Generating Revenue | |||
| FoRx Therapeutics | 18-Dec-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Artios | 17-Nov-2025 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| EpiBiologics | 31-Oct-2025 | Early Stage VC | Drug Discovery | Generating Revenue |
Novartis Venture Fund Exits (183)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Alesta Therapeutics | 01-Sep-2026 | Merger/Acquisition | |
| Immunitas Therapeutics | 12-May-2026 | ||
| Binx | 01-Apr-2026 | ||
| Vivet Therapeutics | 01-Mar-2026 | ||
| YourBio Health | 01-Jan-2026 | ||
| Anokion | 06-Dec-2025 | ||
| Faze Medicines | 12-Oct-2025 | ||
| Capstan Therapeutics | 19-Aug-2025 | ||
| Soteria Biotherapeutics | 06-Jun-2025 | Out of Business | |
| TigaTx | 13-Mar-2025 | Merger/Acquisition |
Novartis Venture Fund Investments by Industry, Year, and Region
Novartis Venture Fund Co-Investors (150)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Forbion | 8 |
|
|
||
| EQT Life Sciences |
|
|
|||
| Johnson & Johnson JJDC |
|
|
|||
| OrbiMed |
|
|
|||
| BioGeneration Ventures |
|
|
Novartis Venture Fund FAQs
-
What is Novartis Venture Fund?
Founded in 1996, Novartis Venture Fund is a corporate venture capital arm of Novartis based in Basel, Switzerland.
-
When was Novartis Venture Fund founded?
Novartis Venture Fund was founded in 1996.
-
Where is Novartis Venture Fund headquartered?
Novartis Venture Fund is headquartered in Basel, Switzerland.
-
What is Novartis Venture Fund's total asset value?
Novartis Venture Fund has around in total assets under management.
-
How many investments has Novartis Venture Fund made?
Novartis Venture Fund has made 361 investments.
-
What has Novartis Venture Fund invested in?
Novartis Venture Fund has made numerous investments in companies like Seawolf Therapeutics, Anaheim Bio, and Kynexis within the Drug Discovery industry.
-
What has Novartis Venture Fund invested in recently?
Novartis Venture Fund's latest investment was on 16-Nov-2026 in Seawolf Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process